Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.560
-0.080 (-4.88%)
At close: Oct 10, 2025, 4:00 PM EDT
1.570
+0.010 (0.64%)
After-hours: Oct 10, 2025, 7:59 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $247.78 million as of October 10, 2025. Its market cap has decreased by -61.94% in one year.
Market Cap
247.78M
Enterprise Value
293.72M
1-Year Change
-61.94%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $247.78M, an increase of 99.33%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 247.78M | -61.87% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
| Dec 1, 2020 | 124.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.50B |
| Johnson & Johnson | 458.96B |
| AbbVie | 407.74B |
| UnitedHealth Group | 332.17B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 231.92B |